Merkel spoke about the cancellation of patents for vaccines from COVID-19

German Chancellor Angela Merkel does not consider the cancellation of patents for them to be a solution to the problem of providing coronavirus vaccines.

The evaluation of the effectiveness of the waiver of intellectual property rights for coronavirus vaccines was previously carried out by the team of US Trade Representative Katherine Tai.

She noted that “the market is not yet able to meet the health needs of developing countries.”

Last Thursday, the Bundestag voted against a proposal to cancel patents for these drugs.

“I do not believe that the suspension of patents is a solution that will provide more people with vaccines. However, I believe that we need the ingenuity and innovative potential of companies, and, in my opinion, this also includes the protection of patents,” Merkel said.

According to her, issuing licenses for the production of vaccines will help provide them to more people, while “patent holders must monitor the quality of products.”

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor

Spelling error report

The following text will be sent to our editors:

135 number 0.244282 time